While previous studies identified the serotonin 5-HT3 receptor in β cells as a mediator of serotonin-induced insulin secretion (47, 62), here we demonstrate that serotonin receptor 3 antagonist (ondansetron) was not able to block serotonin-induced hypoglycemia. This evidence concerns the gene INS and Hypoglycemia.